Testing an Organizational Change Model to Address Smoking in Mental Healthcare
Testing an Organizational Change Model to Address Smoking in Mental Healthcare
批准号:
9886075
负责人:
Robert A Schnoll
金额:
$63.77万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-02 至 2023-02-28
关键词:
AchievementAddressAdherenceAdoptionAffectAmericanBehavior TherapyBehavioralBeliefBipolar DisorderCaringCause of DeathCigaretteClientClinicClinical Practice GuidelineClinical TrialsClinical Trials DesignCommunitiesCommunity HealthcareConsumptionCost AnalysisDataDiseaseEvidence based practiceEvidence based treatmentFDA approvedGeneral PopulationGoalsGuidelinesHealth PersonnelHealth care facilityHealthcareHealthcare SystemsHealthy People 2020Human ResourcesIndividualInfrastructureInterventionLifeLinkMajor Depressive DisorderMeasuresMediator of activation proteinMental HealthMental disordersMentally Ill PersonsMethodsModelingMorbidity - disease rateNational Institute of Mental HealthNicotine DependenceOrganizational ChangePatientsPersonsPharmaceutical PreparationsProviderPsyche structurePublic HealthQuality of lifeRandomizedRandomized Clinical TrialsReportingResearchSchizophreniaSmokerSmokingSmoking Cessation InterventionSourceSpecialistSubgroupTestingTimeTobaccoTobacco Use DisorderTobacco useTrainingUnited States Public Health Serviceadherence ratebarrier to carebasecost effectivecost effectivenesscost-effectiveness ratiodesignevidence baseevidence based guidelinesfollow-uphealth care service organizationhealth care settingsimprovedimproved outcomeincremental cost-effectivenessmembermortalitynovelpreventprogramspublic health relevancereinforcersevere mental illnesssmoking cessationtime usetobacco controltreatment as usualtreatment guidelinesvarenicline
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In contrast to the public health achievement of reducing overall US smoking rates from >50 percent in the 1960s to ~20 percent by 2000, the rate of smoking among those with serious mental illness (SMI) remains 2-3 times greater than in the general population. Recent data has shown that any small decline in smoking rates occurring in the general population in the past decade has not been seen among smokers with an SMI. In fact, 44 percent of all the cigarettes consumed in the US are by individuals with a psychiatric disorder and the number one cause of death among Americans with a psychiatric disorder is a tobacco-related disease. Unfortunately, < 25 percent of smokers with SMI receive evidence-based treatment for their tobacco use disorder (TUD). Transforming the public mental healthcare infrastructure to adhere to guidelines for the provision of evidence-based TUD treatment is an NIMH priority and is part of a national effort to meet Healthy People 2020 target goals for tobacco use. Current FDA-approved medications for TUD and guideline-based behavioral smoking cessation treatments are safe and efficacious for smokers with SMI and public mental healthcare facilities are ideal settings for integrating TUD treatments. Yet, systemic (e.g., lack of training) and cultural (e.g., belief that smoking cessation will cause decompensation) barriers within the mental healthcare system are preventing smokers with SMI from receiving evidence-based TUD treatment. Facilitating the adoption and sustainability of evidence-based practice for TUD within public mental healthcare clinics requires an organization-level intervention to address barriers that hinder effective care. Preliminary studies
by members of the research team in community mental healthcare settings have shown that an organization-level intervention reduces barriers to providing evidence-based TUD treatment and improves clinician adherence to treatment guidelines. Thus, with a cluster-randomized design and 16 community mental healthcare agencies (N=320 personnel, N=800 clients), this study will evaluate the Addressing Tobacco Through Organizational Change (ATTOC) model for: 1) improving provider adherence to guidelines for treating TUD; and 2) reducing client smoking rates, vs. usual care (UC). Non-inferiority testing will determine if the ATTOC model adversely affects client mental health functioning, vs. UC, and the cost-effectiveness of the ATTOC intervention will be assessed. We will also explore changes in barriers as mediators of the effects of the ATTOC model on provider adherence to treatment guidelines and patient smoking and identify key ATTOC components linked to improved outcomes that can be more easily disseminated. If this trial shows that ATTOC can promote evidence-based care for TUD and reduce smoking rates for those with an SMI - and without worsening mental health and in a cost- effective manner - this organizational change model may represent a critical initiative to address tobacco use in an under-served sub-group of smokers and help to attain Healthy People 2020 tobacco use goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Patient-Oriented Research Mentoring Program in Tobacco Dependence Research
-
批准号:10094212
-
项目类别:
-
资助金额:$18.7万
-
财政年份:2018
-
负责人:Robert A Schnoll
-
依托单位:
A Mentoring Program in Patient-Oriented Tobacco Dependence and Implementation Science Research
-
批准号:10700361
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2018
-
负责人:Robert A Schnoll
-
依托单位:
A Patient-Oriented Research Mentoring Program in Tobacco Dependence Research
-
批准号:10350574
-
项目类别:
-
资助金额:$18.7万
-
财政年份:2018
-
负责人:Robert A Schnoll
-
依托单位:
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS
-
批准号:9084516
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2012
-
负责人:Robert A Schnoll
-
依托单位:
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial
-
批准号:9087162
-
项目类别:
-
资助金额:$58.37万
-
财政年份:2012
-
负责人:Robert A Schnoll
-
依托单位:
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial
-
批准号:8683128
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2012
-
负责人:Robert A Schnoll
-
依托单位:
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS
-
批准号:8308814
-
项目类别:
-
资助金额:$49.57万
-
财政年份:2012
-
负责人:Robert A Schnoll
-
依托单位:
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS
-
批准号:8470613
-
项目类别:
-
资助金额:$47.59万
-
财政年份:2012
-
负责人:Robert A Schnoll
-
依托单位:
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial
-
批准号:8515364
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2012
-
负责人:Robert A Schnoll
-
依托单位:
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial
-
批准号:8372446
-
项目类别:
-
资助金额:$64.82万
-
财政年份:2012
-
负责人:Robert A Schnoll
-
依托单位:
Efficacy of Varenicline for Smokless Tobacco Use in India
-
批准号:7630270
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2010
-
负责人:Robert A Schnoll
-
依托单位:
Efficacy of Varenicline for Smokless Tobacco Use in India
-
批准号:8051826
-
项目类别:
-
资助金额:$16.81万
-
财政年份:2010
-
负责人:Robert A Schnoll
-
依托单位:
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
-
批准号:8432880
-
项目类别:
-
资助金额:$56.78万
-
财政年份:2009
-
负责人:Robert A Schnoll
-
依托单位:
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
-
批准号:7651790
-
项目类别:
-
资助金额:$66.58万
-
财政年份:2009
-
负责人:Robert A Schnoll
-
依托单位:
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
-
批准号:7843434
-
项目类别:
-
资助金额:$63.85万
-
财政年份:2009
-
负责人:Robert A Schnoll
-
依托单位:
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
-
批准号:8225360
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2009
-
负责人:Robert A Schnoll
-
依托单位:
Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine
-
批准号:7699975
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2009
-
负责人:Robert A Schnoll
-
依托单位:
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
-
批准号:8034381
-
项目类别:
-
资助金额:$62.59万
-
财政年份:2009
-
负责人:Robert A Schnoll
-
依托单位:
Assessment of a Teachable Moment for Smoking Cessation
-
批准号:8013880
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2007
-
负责人:Robert A Schnoll
-
依托单位:
Assessment of a Teachable Moment for Smoking Cessation
-
批准号:7758344
-
项目类别:
-
资助金额:$31.16万
-
财政年份:2007
-
负责人:Robert A Schnoll
-
依托单位:
海外基金